Amazon Just Put the Biggest Trade of the Decade on the Wrong Side—and Big Pharma Is Paying for It
Amazon’s new GLP-1 pricing is dragging Novo Nordisk and Eli Lilly stocks lower.
Original Source
Read the full article at Inc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.